Results 111 to 120 of about 67,661 (149)

Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer. [PDF]

J Bras Pneumol, 2015
Lopes GL, Vattimo EF, Castro Junior Gd.
europepmc   +1 more source

Perfil proteómico (micromatrices proteínicas) del líquido pleural en pacientes con derrame pleural maligno y tuberculoso

, 2016
Fundamento: La citología del líquido pleural (LP) es poco sensible y tiene dificultades para diferenciar entre mesotelioma maligno (MPM) y adenocarcinoma (ADC) pulmonar o linfoma de tuberculosis (TBC). Objetivo: Descubrir “perfiles proteómicos” en el LP que diferencien dichas entidades.
openaire   +1 more source

[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]. [PDF]

Aten Primaria, 2004
Vich Pérez P, Ruiz Arribas C, Collados Navas R, Pastor-Sánchez R.   +3 more
europepmc   +1 more source

Tratamiento empírico de las infecciones del adulto. [PDF]

FMC, 2016
Monedero Mira MJ, Sales MB, Domingo CG, Monedero Mira MJ, Saura BP, Mallen GR, Porcar LT.   +6 more
europepmc   +1 more source

High-grade Pleomorphic Sarcoma Associated with Metallosis in a Patient with Total Hip Arthroplasty. [PDF]

Rev Bras Ortop (Sao Paulo)
Campos RS, Meohas W, Ferradosa AS, Freire da Costa AFA, Guimarães JAM, Duarte MEL.   +5 more
europepmc   +1 more source

Facing tuberculosis during the COVID-19 pandemic: the perspective of those who experienced it. [PDF]

Rev Bras Enferm
Farias TEBA, Sthal HC, Silva VME, Araújo AJ, Hino P, Gonzales RIC, Bertolozzi MR, Figueiredo TMRM.   +7 more
europepmc   +1 more source

Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024. [PDF]

Arq Bras Cardiol
Magalhães TA, Carneiro ACC, Moreira VM, Trad HS, Lopes MMU, Cerci RJ, Nacif MS, Schvartzman PR, Chagas ACP, Costa IBSDS, Schmidt A, Shiozaki AA, Montenegro ST, Piegas LS, Zapparoli M, Nicolau JC, Fernandes F, Hadlich MS, Ghorayeb N, Mesquita ET, Gonçalves LFG, Ramires FJA, Fernandes JL, Schwartzmann PV, Rassi S, Torreão JA, Mateos JCP, Beck-da-Silva L, Silva MC, Liberato G, Oliveira GMM, Feitosa Filho GS, Carvalho HDSM, Markman Filho B, Rocha RPS, Azevedo Filho CF, Taratsoutchi F, Coelho-Filho OR, Kalil Filho R, Hajjar LA, Ishikawa WY, Melo CA, Jatene IB, Albuquerque AS, Rimkus CM, Silva PSDD, Vieira TDR, Jatene FB, Azevedo GSAA, Santos RD, Monte GU, Ramires JAF, Bittencourt MS, Avezum A, Silva LSD, Abizaid A, Gottlieb I, Precoma DB, Szarf G, Sousa ACS, Pinto IMF, Medeiros FM, Caramelli B, Parga Filho JR, Santos TSGD, Prazeres CEED, Lopes MACQ, Avila LFR, Scanavacca MI, Gowdak LHW, Barberato SH, Nomura CH, Rochitte CE.   +72 more
europepmc   +1 more source

Avaliação citogenética molecular de células do líquido pleural de pacientes com derrame pleural maligno [PDF]

, 2015
openaire   +1 more source

Synchronous diagnosis of primitive papillary adenocarcinomas: beyond the realm of probability.

J Bras Pneumol, 2013
Ferreira PG, Matos P, Ferreira AJ.
europepmc   +1 more source

Parámetros asociados a la eficacia de la pleurodesis y a la supervivencia en pacientes con derrame pleural maligno

, 2017
La pleurodesis química es una opción terapéutica para pacientes sintomáticos con derrame pleural maligno (DPM) y una expectativa de vida >2-3 meses. La guía americana sobre el manejo del DPM, en el año 2000, estableció los criterios de eficacia de la pleurodesis actualmente vigentes, por lo que muchos de los trabajos realizados sobre eficacia y ...
openaire   +1 more source